Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

CHO Cell Line Development

Rapid and High-Yield IND-Ready cell line development for clinical applications.

In today’s fast-paced biotech landscape, achieving rapid and high-yield production of therapeutic proteins is crucial. CHOExpress® leverages over 20 years of expertise to offer industry-leading CHO cell lines and scalable manufacturing solutions. 

WHY CHOOSE OUR CHOEXPRESS®

Our approach ensures that you can meet your production goals efficiently and effectively, addressing the growing demand for biologics.

Benefits of using ExcellGene’s CHOExpress®

Speed

From DNA to stable clone in just 8 weeks, CHOExpress® ensures rapid development timelines to keep your projects on track.

Scalability

Scale up to 5,000 liters without any loss in productivity, making it easier to meet commercial manufacturing demands​.

High Titers

Achieve titers over 14 g/L with fully chemically defined media, ensuring consistent and high-quality production.​

Clone Stability

Over 95% (or 98%) of our clones are stable, guaranteeing reliable and long-term production capabilities.​​

Flexibility

Choose from a variety of media and feeds, with licensing options available to suit your specific needs.​

Versatile Production

Our platform supports the production of monoclonal antibodies, bispecifics, fusion proteins, biosimilars, and virus surface proteins, catering to a wide range of therapeutic needs.

Comprehensive support

We offer end-to-end support, from gene integration to filing of the MAA/BLA  including process development and optimization, and assay development.

HOW WE CAN HELP

Our CHOExpress® platform is designed to handle a variety of production needs.

  • Innovative products: Our fast-track program gives you the competitive edge over your competitors.
  • Bispecifics and multispecifics: Our fine-tuned chain ratios coupled with efficient integration and meticulous clone selection process for optimal protein quality and titer.
  • Biosimilars: Benefit from our high-yielding clones and scalable production capabilities for cost-effective solutions.
  • Difficult to express proteins: We offer CRISPR-like genome engineering to reach commercially viable titers and/or protein quality.